$BMEA 8-K SEC Filings

Filed On	Filing
14 Oct 2026	8-K: Regulation FD Disclosure; Other Events Exhibit 99.1 GLP-131 Phase 1 Study of BMF-650 in Otherwise Healthy Overweight or Obese Adult Participants Week 4 Topline Results October 13, 2026
22 Sep 2026	8-K: Other Events On September 22, 2026, Biomea Fusion, Inc. (the “Company”) updated the anticipated timing for topline results from the Company’s ongoing Phase I GLP-131 trial for BMF-650 in obese, otherwise healthy volunteers, which are now expected in ...
05 Aug 2026	8-K: Financial Statements and Exhibits
11 Jun 2026	8-K: Submission of Matters to a Vote of Security Holders
11 May 2026	8-K: Results of Operations and Financial Condition
28 Apr 2026	8-K: Regulation FD Disclosure; Other Events
24 Mar 2026	8-K: Results of Operations and Financial Condition
25 Feb 2026	8-K: Regulation FD Disclosure
14 Jan 2026	8-K: Regulation FD Disclosure; Other Events
04 Nov 2025	8-K: Results of Operations and Financial Condition
07 Oct 2025	8-K: Entry into a Material Definitive Agreement; Other Events
06 Oct 2025	8-K: Other Events
05 Aug 2025	8-K: Results of Operations and Financial Condition
24 Jul 2025	8-K: Departure/Election of Directors or Officers; Compensation
20 Jun 2025	8-K: Entry into a Material Definitive Agreement
18 Jun 2025	8-K: Entry into a Material Definitive Agreement; Other Events
17 Jun 2025	8-K: Regulation FD Disclosure; Other Events
13 Jun 2025	8-K: Submission of Matters to a Vote of Security Holders
05 May 2025	8-K: Results of Operations and Financial Condition
31 Mar 2025	8-K: Results of Operations and Financial Condition

Comments